| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/12/2004 | US20040029883 Beta-amino acid compounds as integrin antagonists |
| 02/12/2004 | US20040029880 Anthranyl amides and their use as medicaments |
| 02/12/2004 | US20040029877 Immune response induction; viricides; anticancer agents |
| 02/12/2004 | US20040029873 Antiinflammatory agents; Alzheimer's disease; atherosclerosis; inflammatory bowel diseases; antiarthritic agents |
| 02/12/2004 | US20040029869 Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine |
| 02/12/2004 | US20040029868 Multiple sclerosis; atherosclerosis; inflamamtory bowel diseases; asthma |
| 02/12/2004 | US20040029866 Polymerase enzyme inhibitors |
| 02/12/2004 | US20040029851 Therapy for oxidation stresses; complex of drug and enzyme mimetics |
| 02/12/2004 | US20040029850 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases |
| 02/12/2004 | US20040029847 Anticancer agents; contraceptives |
| 02/12/2004 | US20040029846 Cushing disease; antidepressant; modulate immunology response |
| 02/12/2004 | US20040029820 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/12/2004 | US20040029816 Hepatoprotective activity of 10-O-P-hydroxybenzoyiaucubin |
| 02/12/2004 | US20040029803 Binding to apoptosis cells |
| 02/12/2004 | US20040029801 Antiinflammatory agents; immunosuppressants; inflammatory bowel disease; antiarthritic agents; autoimmune diseases; administering drug and immunosuppressant |
| 02/12/2004 | US20040029799 Medicament containing activated antithrombin III |
| 02/12/2004 | US20040029793 Genetic engineering; antibodies; antiinflammatory agents, circulation diseases, anticancer agents, antidiabetic agents, gastrointestinal disorders |
| 02/12/2004 | US20040029751 Preparatiom for douches and/or irrigations of natural or pathological cavities in the human body |
| 02/12/2004 | US20040029279 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 02/12/2004 | US20040029247 Regulation of human adenylate cyclase, type iv |
| 02/12/2004 | US20040029227 Prolonging expression of an exogenous gene in a cell transduced with the gene; for treatment of brain disorders like tumours, Alzheimer's disease, Parkinson's disease, lateral amyotrophic sclerosis, neurodegenerative disorders |
| 02/12/2004 | US20040029224 Used for determination of ligands (agonists), preparation of antibodies and antisera, construction of recombinant receptor protein expression systems, development of receptor binding assay systems and screening of pharmaceutical candidates |
| 02/12/2004 | US20040029197 Novel human cancer/testis antigen and gene thereof |
| 02/12/2004 | US20040029179 Higher molecular weight entities and uses therefor |
| 02/12/2004 | US20040029178 For anti-obesity/appetite enhancing drugs; prolactin inhibitors |
| 02/12/2004 | US20040029163 Novel tissue-specific secretory polypeptide and dna thereof |
| 02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040028815 Combinatorial synthesis |
| 02/12/2004 | US20040028734 Muscular disorders; antiproliferative agents; antiinflammatory agents |
| 02/12/2004 | US20040028728 Liposome preparations |
| 02/12/2004 | US20040028727 Dry formulation for transcutaneous immunization |
| 02/12/2004 | US20040028703 Genetic engineered, low molecular weight drug; therapy, vaccine; extraction of Clostridium |
| 02/12/2004 | US20040028692 Sensitization process for antigen-presenting cells and means for implementing the process |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028658 Methods of organ regeneration |
| 02/12/2004 | US20040028643 Compositions for retarding skin aging |
| 02/12/2004 | US20040028619 Antiinflammatory agents; bronchodilator agents; antihistamines; respiratory system disorders |
| 02/12/2004 | US20040028615 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/12/2004 | US20040026237 Ionization device which is mounted with gold pole or silver pole |
| 02/12/2004 | DE10233366A1 In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinone derivatives, their preparation and their use as medicaments |
| 02/12/2004 | CA2494632A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/12/2004 | CA2494616A1 Furanthiazole derivatives as heparanase inhibitors |
| 02/12/2004 | CA2494288A1 Novel salt and polymorphs of desloratadine hemifumarate |
| 02/12/2004 | CA2494121A1 Modulation of mesenchymal cells via iga-receptors |
| 02/12/2004 | CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | CA2494074A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/12/2004 | CA2493637A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/12/2004 | CA2397684A1 Mitochondrially targeted antioxidants |
| 02/11/2004 | EP1388534A2 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 02/11/2004 | EP1388344A1 Composition comprising Salvia Miltiorrhizae, Ginseng, Borneol for treating heart disease, and cerebrovascular diseases |
| 02/11/2004 | EP1388340A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
| 02/11/2004 | EP1387886A2 Proteases |
| 02/11/2004 | EP1387840A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors |
| 02/11/2004 | EP1387838A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP1387826A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 02/11/2004 | EP1387701A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy |
| 02/11/2004 | EP1387697A2 Methods of treating antibody-mediated pathologies using agents which inhibit cd21 |
| 02/11/2004 | EP1387670A2 Immune modulation device for use in animals |
| 02/11/2004 | EP1387660A1 Use of 3-position cyclosporin derivatives for hair growth |
| 02/11/2004 | EP1299356B1 Novel compounds |
| 02/11/2004 | EP1183251B1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 02/11/2004 | EP1144393B1 Benzoxazole derivatives for use as integrin inhibitors |
| 02/11/2004 | EP1079808B1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 02/11/2004 | EP1042300B1 Phthalazine derivatives useful as phosphodiesterase 4 inhibitors |
| 02/11/2004 | EP1007020B1 9-cis-RETINOIC ACID FOR CELL-MEDIATED IMMUNE DISEASES |
| 02/11/2004 | EP0892640B1 Enteric-coated pharmaceutical compositions of mycophenolate |
| 02/11/2004 | EP0835125B1 Cd4-derived peptides that inhibit immune responses |
| 02/11/2004 | CN1474871A Inhibitor proteins |
| 02/11/2004 | CN1474813A Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists |
| 02/11/2004 | CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor |
| 02/11/2004 | CN1474809A Cyanopyrolidine derivatives |
| 02/11/2004 | CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474693A Use of thienopyrimidines |
| 02/11/2004 | CN1473854A Recombined IL4 antibody for treating IL4 insertion diseases |
| 02/11/2004 | CN1473620A Capsule of cordyceps |
| 02/11/2004 | CN1473602A Extracting and preparing process for Echinacea prupurea and its products |
| 02/11/2004 | CN1473573A 远红外多功能材料 Far-infrared multifunctional materials |
| 02/11/2004 | CN1473565A Benzopyrany/derivatives and antiallergic agent |
| 02/11/2004 | CN1137889C Novel tricycloacylamide compound, its preparation method and medicinal composition containing them |
| 02/11/2004 | CN1137888C Inhibitor of cysteninyl aspartic acid proteinase |
| 02/11/2004 | CN1137727C Process for preparation of immune globulin for introvenous injection by dual inactivation of virus without protectives |
| 02/11/2004 | CN1137726C Method of prolonged suppression of humoral immunity |
| 02/11/2004 | CN1137717C Capsule for dispelling wind and detoxicating body |
| 02/11/2004 | CN1137715C Chinese medicinal preparation for treating erythematosus |
| 02/11/2004 | CN1137680C Aerosol compositions |
| 02/10/2004 | US6689922 Vitamin D analogues |
| 02/10/2004 | US6689886 Treatment of inflammation and other immune disorders |
| 02/10/2004 | US6689879 Nucleotide sequences coding nvelope protein for use in the prevention of viral diseases |
| 02/10/2004 | US6689876 Cloning and sequencing of allergens of dermatophagoides |
| 02/10/2004 | US6689869 Labeled humanized anti-CD18 antibodies and fragments and kits comprising same |
| 02/10/2004 | US6689866 Isolated polypeptide comprising specified amino acid sequence; membrane-bound or secreted polypeptide having semaphorin-like activity |
| 02/10/2004 | US6689804 Imidazo-imidazole |
| 02/10/2004 | US6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 02/10/2004 | US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/10/2004 | US6689790 Substituted triazolopyridine compounds |
| 02/10/2004 | US6689784 Controlling cell apoptosis |